CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 41 enrolled
Drug / intervention
Video DOT+behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03677986
NCT03677986N/ACompleted

Buprenorphine Treatment Engagement and Overdose Prevention in Opioid Users

Johns Hopkins University·interventional·Posted Sep 19, 2018·Updated Feb 20, 2024

In Brief

A clinical study evaluating Video DOT+ for Opioid-use Disorder. Completed, enrolled 41 participants across 1 site.

Detailed Summary

Office-based buprenorphine could be expanded to treat many of the opioid users who are not in treatment and who are at great risk for opioid overdose, but effective approaches are needed to help individuals with opioid use disorder initiate and remain in office-based buprenorphine treatment. Investigators propose to develop and pilot test a novel intervention that will combine video-based directly observed therapy and incentives to promote buprenorphine treatment engagement and adherence in out-of-treatment opioid users.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 19, 2018
Enrollment StartMay 1, 2019
Primary CompletionJul 28, 2020
Study CompletionOct 20, 2020
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 7.8 years ago

Interventions

Video DOT+behavioral

Participants will receive financial incentives for recording and submitting videos of themselves taking their daily buprenorphine dose.